Recall archive / FDA device enforcement
Custom procedural convenience kits and trays, cardiac, labeled as: a) HEART CATHETERIZATION TRAY, kit number JRHC45G;... — FDA record Z-0817-2024
Reported ongoing
Status as reported in the agency record. FDA warns that enforcement status may not track the current recall lifecycle; check the current official notice.
Source date Nov 29, 2023. Retrieved Oct 1, 2026. Last updated Oct 1, 2026.
Archive changed Oct 1, 2026. USDA FSIS records are unavailable; check FSIS directly. Source coverage and dates.
What the record says
- Product
- Custom procedural convenience kits and trays, cardiac, labeled as: a) HEART CATHETERIZATION TRAY, kit number JRHC45G; b) TAVR PACK, kit number LLTV10; c) CATH PED LF SJH, kit number SJCA21F; d) CATH HEART ADL LF SJH, kit number SJCH22F; e) INT RAD PORTS-LF - 206060, kit number UDIR58AL
- Reason
- During an internal investigation, ACS identified that several components were "piggybacked" to ACS trays and subjected to the ACS sterilization process. There is no supporting documentation stating the "piggybacked" components were assessed to determine if they were suitable for exposure to elevated temperatures for an extended period of time and further exposure to sterilization. As a result, the piggybacked components may (1) have a loss/lack of functionality, (2) loss of drug efficacy, if applicable, and (3) may have had higher than specified EO residuals.
- Classification
- Class II
- Recalling firm
- American Contract Systems, Inc.
- Quantity
- 4394 units
- Agency-reported status
- Ongoing
- Source record identifier
- Z-0817-2024
What the recall classes mean. Classification is an agency assessment, not individual medical advice.
Lot and product identifiers
| Label field | Details supplied by the agency |
|---|---|
| Lot, code or applicability | a) JRHC45G, UDI/DI 00191072164240, Lot Numbers: 912231, exp. 3/29/2024; 920231, exp. 3/21/2024; 952231, exp. 2/17/2024; 963231, exp. 2/6/2024; 976231, exp. 6/2/2023; 654221, exp. 12/12/2023; 714221, exp. 10/13/2023; 717221, exp. 6/7/2023; 766221, exp. 8/22/2023; 814221, exp. 7/5/2023; b) LLTV10, UDI/DI 00191072183255, Lot Numbers: 644221, exp. 12/22/2023; 973231, exp. 1/27/2024; 952231, exp. 2/17/2024; 924231, exp. 3/17/2024; c) SJCA21F, UDI/DI None, Lot Numbers: 666221, exp. 11/30/2023; 701221, exp. 10/26/2023; 747221, exp. 9/10/2023; 779221, exp. 8/9/2023; 807221, exp. 7/12/2023; 846221, exp. 6/3/2023; 919231, exp. 3/22/2024; 954231, exp. 2/15/2024; 988231, exp. 1/12/2024; d) SJCH22F, UDI/DI None, Lot Numbers: 670221, exp. 11/26/2023; 708221, exp. 10/19/2023; 747221, exp. 9/10/2023; 795221, exp. 7/24/2023; 834221, exp. 6/15/2023; 873221, exp. 5/7/2023; 937231, exp. 3/4/2024; 991231, exp. 1/9/2024; e) UDIR58AL, UDI/DI None, Lot Numbers: 682221, exp. 11/14/2023; 638221, exp. 7/31/2023; 963231, exp. 2/6/2024; 925231, exp. 3/16/2024; 883231, exp. 10/30/2023 |
Match all identifying details in the current notice. A brand name alone is not enough.
Distribution
US Nationwide distribution.
States below are derived from the distribution text, including nationwide wording. They are not inferred from the firm's address.
- Alaska
- Alabama
- Arkansas
- Arizona
- California
- Colorado
- Connecticut
- Delaware
- Florida
- Georgia
- Hawaii
- Iowa
- Idaho
- Illinois
- Indiana
- Kansas
- Kentucky
- Louisiana
- Massachusetts
- Maryland
- Maine
- Michigan
- Minnesota
- Missouri
- Mississippi
- Montana
- North Carolina
- North Dakota
- Nebraska
- New Hampshire
- New Jersey
- New Mexico
- Nevada
- New York
- Ohio
- Oklahoma
- Oregon
- Pennsylvania
- Rhode Island
- South Carolina
- South Dakota
- Tennessee
- Texas
- Utah
- Virginia
- Vermont
- Washington
- Wisconsin
- West Virginia
- Wyoming
Dates in the source
- Report date
- Feb 7, 2024
- Recall initiation date
- Nov 29, 2023
- Center classification date
- Jan 26, 2024
FDA company pages use the listing date; enforcement records use initiation dates; CPSC uses recall date; NHTSA uses report-received date. These dates are not interchangeable.